Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$61.31
1.242.06%
At close: Jan 7, 4:00 PM EST
$61.31
N/A
After Hours: 4:00 PM EST
Comments
Loading...
BioMarin Pharmaceutical (BMRN) Stock Price, Quote, News & History
BMRNNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioMarin Pharmaceutical (BMRN) stock?
You can purchase shares of BioMarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.
Who are BioMarin Pharmaceutical (BMRN) competitors?
Other companies in BioMarin Pharmaceutical’s space includes: Avidity Biosciences Inc (NASDAQ:RNA), Exact Sciences Corp (NASDAQ:EXAS), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Roivant Sciences Ltd (NASDAQ:ROIV).
What is the forecast, or price target, for BioMarin Pharmaceutical (BMRN) stock?
BioMarin Pharmaceutical has a consensus price target of $93.32.
What is the current price for BioMarin Pharmaceutical (BMRN)?
The stock price for BioMarin Pharmaceutical (NASDAQ: BMRN) is $61.31 last updated January 7, 2026 at 4:00 PM EST.
Does BioMarin Pharmaceutical (BMRN) pay a dividend?
There are no upcoming dividends for BioMarin Pharmaceutical.
When is BioMarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
BioMarin Pharmaceutical does not have any upcoming earnings scheduled.
Is BioMarin Pharmaceutical (BMRN) going to split?
There is no upcoming split for BioMarin Pharmaceutical.
What sector and industry does BioMarin Pharmaceutical (BMRN) operate in?
BioMarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
